Diagnostic Formulation: How to Write a Differential Diagnosis
What Is a Diagnostic Formulation?
A diagnostic formulation is a structured clinical document that presents and justifies a client's psychiatric diagnosis through systematic differential reasoning. It goes beyond simply listing DSM-5-TR diagnoses — it explains the clinician's reasoning process: what diagnoses were considered, what evidence supports or contradicts each diagnostic possibility, and how the clinician arrived at the final diagnostic conclusion.
The DSM-5-TR Handbook of Differential Diagnosis, authored by Michael B. First, provides a six-step approach that moves from ruling out malingering and factitious disorders, to determining whether symptoms are substance-induced or due to a medical condition, to identifying the primary disorder, to establishing the boundary between disorder and normality, to differentiating adjustment disorders from other conditions, and finally to establishing comorbidities. This systematic approach prevents the two most common diagnostic errors: premature closure (stopping at the first plausible diagnosis) and anchoring bias (overcommitting to an initial impression without considering alternatives).
A well-documented diagnostic formulation protects the clinician by demonstrating clinical reasoning, supports treatment planning by ensuring the correct target is identified, and serves as a communication tool for other providers, insurance reviewers, and legal proceedings where diagnostic accuracy is scrutinized.
When You Need It
- When conducting a comprehensive diagnostic evaluation, particularly for complex or ambiguous presentations
- When the differential diagnosis includes conditions with overlapping symptom profiles (e.g., depression vs. bipolar, PTSD vs. BPD, ADHD vs. anxiety)
- When a client has been assigned multiple diagnoses by previous providers and diagnostic clarity is needed
- When writing a psychological evaluation or assessment report that requires documented clinical reasoning
- When insurance, legal, or institutional requirements demand documentation of how a diagnosis was determined
- When training or supervising clinicians in diagnostic reasoning
Key Components
Presenting Symptoms
A detailed, behavioral description of the client's current symptoms — not yet filtered through diagnostic categories. Document what the client reports and what you observe, including onset, duration, frequency, severity, and functional impact. Use the client's own language alongside clinical terminology.
The Six-Step Differential Process
Step 1: Rule out malingering and factitious disorders. Consider whether the client has an external incentive (legal, financial, occupational) to exaggerate or fabricate symptoms. This does not require accusation — it requires documentation that the possibility was considered and the clinical basis for your conclusion.
Step 2: Rule out substance-induced etiology. Determine whether the symptoms are attributable to the physiological effects of a substance (alcohol, drugs, medications). This requires a thorough substance use history and, in some cases, laboratory testing. The temporal relationship between substance use and symptom onset is the key diagnostic criterion.
Step 3: Rule out general medical conditions. Determine whether the symptoms are attributable to a medical condition (e.g., hypothyroidism causing depressive symptoms, pheochromocytoma causing panic-like symptoms). Coordinate with the client's primary care provider and request relevant medical workup.
Step 4: Identify the primary disorder. Based on the symptom picture, determine which DSM-5-TR diagnosis best accounts for the presentation. Use the DSM-5-TR decision trees and differential diagnosis tables to systematically compare the client's symptoms against diagnostic criteria for each condition under consideration.
Step 5: Establish the boundary with normality. Determine whether the symptoms meet the threshold for clinical significance — that is, whether they cause clinically significant distress or functional impairment. Normal reactions to stressors (grief, adjustment) must be distinguished from clinical disorders.
Step 6: Address comorbidity. Determine whether the client meets criteria for additional diagnoses beyond the primary disorder. Document each comorbid condition with supporting evidence. Note which symptoms are attributable to which diagnosis to avoid double-counting.
Rule-In and Rule-Out Reasoning
For each diagnosis considered, document the evidence that supports (rules in) and contradicts (rules out) the diagnosis. This head-to-head comparison is the core of the differential — it demonstrates that you considered alternatives and arrived at your conclusion through systematic analysis, not assumption.
Provisional and Deferred Diagnoses
When the available data is insufficient to confirm or exclude a diagnosis, document it as provisional or deferred. Specify what additional information would be needed to resolve the diagnostic question (e.g., "Provisional diagnosis of Bipolar II Disorder pending mood diary and collateral history").
Comorbidity Documentation
When multiple diagnoses co-occur, document how they relate to one another. Are they independent conditions? Does one exacerbate the other? Is one secondary to the other? This relational documentation informs treatment prioritization.
Diagnostic Formulation — Complex Differential (Depression vs. Bipolar II vs. ADHD)
Client: R.J. | Age: 27 | Date: 03/20/2026 Clinician: [Name], PsyD | Referral Source: Self-referred; previously diagnosed with MDD by PCP
Presenting Symptoms: R.J. is a 27-year-old woman who presents with persistent low mood, fatigue, difficulty concentrating, and "feeling stuck." She reports that these symptoms have been present in varying degrees since adolescence but have worsened over the past year following a breakup and a change in job responsibilities. She describes difficulty completing tasks at work ("I start things and can't finish them"), chronic disorganization, procrastination, and a pattern of intense short-term interests followed by abandonment. She reports periods of high energy and productivity lasting several days, during which she takes on multiple projects, sleeps less (4-5 hours without feeling tired), and feels "wired and confident," followed by crashes into low mood and inertia. She has been on sertraline 100mg for the past 18 months, prescribed by her PCP for depression, with limited improvement. PHQ-9: 14 (moderate). GAD-7: 8 (mild).
Previous Diagnoses:
- Major Depressive Disorder, recurrent (diagnosed by PCP, 2024)
- "Possible ADHD" (suggested by a college counselor in 2019, never formally evaluated)
Differential Diagnostic Analysis:
Major Depressive Disorder, Recurrent (F33.1) — PARTIALLY SUPPORTED
Evidence for: Client endorses depressed mood, anhedonia, fatigue, difficulty concentrating, and feelings of worthlessness that meet duration criteria (most of the day, more than half the days, for periods exceeding two weeks). Her PHQ-9 of 14 is consistent with moderate depression. She has a family history of depression (mother treated with SSRIs). Her symptoms cause clinically significant impairment in occupational and social functioning.
Evidence against: Her depressive symptoms have only partially responded to adequate SSRI treatment (sertraline 100mg for 18 months), raising the question of whether MDD is the complete diagnostic picture. Her reported periods of elevated mood, increased energy, decreased need for sleep, and increased goal-directed activity are not accounted for by an MDD diagnosis and warrant evaluation for a bipolar spectrum condition. Additionally, her lifelong pattern of concentration difficulty, disorganization, and task completion problems predates the onset of mood episodes, suggesting a possible attentional disorder independent of depression.
Bipolar II Disorder (F31.81) — UNDER CONSIDERATION
Evidence for: Client describes discrete periods lasting three to five days characterized by elevated or expansive mood, markedly decreased need for sleep (4-5 hours without fatigue), increased goal-directed activity (taking on multiple projects simultaneously), and subjective sense of increased energy and confidence. These episodes represent a change from her baseline and are noticeable to her roommate, who describes her as "a different person" during these periods. These features are consistent with DSM-5-TR criteria for hypomanic episodes. The pattern of depressive episodes alternating with hypomanic periods is the hallmark of Bipolar II. Her partial response to SSRI monotherapy is consistent with bipolar depression, which characteristically responds poorly to antidepressants alone and may be worsened by them.
Evidence against: The client has difficulty reliably dating the onset and duration of the described high-energy periods — she is uncertain whether they consistently last at least four days (the DSM-5-TR minimum for hypomania). She denies grandiosity, pressured speech, flight of ideas, and risky behavior during these periods. No collateral source has described the episodes as clearly problematic or impairing. The periods may represent normal mood variation or ADHD-related hyperfocusing rather than true hypomania. Prospective mood charting would clarify this question.
Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive (F90.0) — SUPPORTED
Evidence for: Client reports a lifelong pattern of difficulty sustaining attention, chronic disorganization, frequent careless mistakes, difficulty following through on tasks, losing necessary items, and being easily distracted. These symptoms were present in childhood — she recalls being described as "spacey" and "not working up to her potential" by teachers, and she reports that homework completion was a chronic struggle throughout school despite above-average intelligence. Her academic performance was inconsistent ("A's on tests, C's on homework"). These inattentive symptoms predate the onset of mood disturbances and are present even during euthymic periods, distinguishing them from mood-related concentration impairment. Review of prior school records (report cards from grades 3, 5, and 8) documents teacher comments about inattention, disorganization, and incomplete work.
Evidence against: The client was never formally diagnosed or treated for ADHD in childhood, and formal neuropsychological testing has not been conducted. Her childhood symptoms were attributed to "laziness" and "not trying hard enough" by her parents, which is common for girls with predominantly inattentive ADHD but does not constitute a prior clinical diagnosis. Adult ADHD rating scales (ASRS-5) administered today yielded a score consistent with probable ADHD, but these are screening instruments, not diagnostic measures.
Substance-Induced and Medical Etiologies — RULED OUT Client denies current substance use other than occasional social alcohol (1-2 drinks per month). She denies cannabis, stimulant, or other drug use. Recent thyroid panel and CBC from PCP are within normal limits. No medical conditions identified that would account for the symptom picture.
Diagnostic Conclusions:
-
Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Presentation (F90.0) — Supported by lifelong pattern of inattentive symptoms predating mood disorder, corroborated by school records, functionally impairing across settings, and present during euthymic periods. Formal neuropsychological testing recommended to confirm.
-
Major Depressive Disorder, Recurrent, Moderate (F33.1) — Supported by recurrent depressive episodes meeting DSM-5-TR criteria, family history, and current PHQ-9. Retained as a diagnosis, but diagnostic clarity regarding Bipolar II is needed.
-
Bipolar II Disorder (F31.81) — Provisional — The reported high-energy periods have features suggestive of hypomania but do not yet clearly meet DSM-5-TR duration and severity criteria. Prospective mood charting over the next 8-12 weeks is recommended, along with collateral history from the client's roommate, to determine whether these episodes meet hypomania criteria. If Bipolar II is confirmed, the MDD diagnosis would be subsumed under the bipolar diagnosis and the treatment plan (particularly medication management) would change significantly.
Clinical Reasoning Note: The distinction between Bipolar II and recurrent MDD with comorbid ADHD is critical for treatment planning. If Bipolar II is confirmed, SSRI monotherapy is contraindicated (risk of mood destabilization) and a mood stabilizer would be the first-line pharmacological intervention. If the high-energy periods are attributable to ADHD-related hyperfocusing rather than true hypomania, the current SSRI may be appropriate with the addition of a stimulant for ADHD. The diagnostic plan (mood charting, collateral history, neuropsychological testing) is designed to resolve this differential within 8-12 weeks.
Diagnostic Plan:
- Prospective mood charting (daily) for 8-12 weeks to capture the duration, frequency, and character of elevated mood periods
- Collateral interview with client's roommate (with client consent) regarding observable mood and behavior changes
- Referral for neuropsychological evaluation to confirm ADHD and rule out cognitive contributions to concentration difficulty
- Coordinate with PCP regarding medication management — recommend holding SSRI at current dose pending diagnostic clarification; do not add stimulant until Bipolar II is confirmed or ruled out
- Reassess diagnostic formulation at 12-week follow-up
This is a sample for educational purposes only — not real patient data.
How to Write It Step by Step
Step 1: Begin with a thorough, unbiased symptom inventory. Before considering diagnostic categories, document the full range of symptoms the client presents. Record onset, duration, frequency, severity, and context. Use the client's language alongside clinical descriptions. This raw symptom picture is the foundation for all subsequent reasoning.
Step 2: Generate a differential diagnosis list. Based on the symptom inventory, identify all DSM-5-TR diagnoses that could plausibly account for the presentation. Cast a wide net — it is better to consider and systematically exclude a diagnosis than to miss it through premature closure. Use the DSM-5-TR decision trees to systematically identify candidate diagnoses.
Step 3: Apply the six-step process. Work through the six steps described above: rule out malingering, substance-induced conditions, and medical etiologies before identifying the primary disorder and addressing comorbidity.
Step 4: Document rule-in and rule-out evidence for each diagnostic possibility. For each candidate diagnosis, list the specific symptoms and history that support it and the specific symptoms and history that argue against it. This head-to-head comparison is the intellectual core of the differential.
Step 5: Arrive at diagnostic conclusions. Based on the differential analysis, state your diagnostic conclusions. For confirmed diagnoses, cite the supporting evidence. For provisional diagnoses, state what additional information would be needed to confirm or exclude them. For ruled-out diagnoses, briefly note the reason for exclusion.
Step 6: Document the diagnostic plan. If diagnostic questions remain unresolved, specify the steps you will take to resolve them — mood charting, collateral history, neuropsychological testing, laboratory workup, or longitudinal observation. Include timelines for reassessment.
Step 7: Link the diagnostic formulation to treatment planning. Explain how the diagnosis (or diagnostic uncertainty) affects treatment decisions. If the differential has treatment-critical implications (e.g., SSRI contraindication in bipolar disorder), document this explicitly.
Common Mistakes
-
Premature diagnostic closure. Stopping at the first plausible diagnosis without considering alternatives is the most dangerous diagnostic error. If a client presents with depressed mood and concentration difficulty, "Major Depressive Disorder" may be correct — but it may also be bipolar depression, ADHD, PTSD, substance-related depression, or a medical condition. The differential should demonstrate that alternatives were considered.
-
Diagnosing by checklist without clinical judgment. Meeting the minimum symptom count for a DSM-5-TR diagnosis does not automatically warrant the diagnosis. Clinical significance, functional impairment, duration, and context all matter. A person who meets five criteria for MDD two weeks after the death of a parent may be experiencing normal grief, not a clinical disorder.
-
Failing to document rule-out reasoning. Writing "R/O Bipolar II" on a diagnostic list without documenting what evidence supports or contradicts the diagnosis, or what steps you are taking to resolve the question, provides no clinical value. A rule-out should always be accompanied by a plan to rule it in or out.
-
Ignoring base rates. Some diagnoses are rare; others are common. A 25-year-old presenting with concentration difficulty in a primary care setting is far more likely to have ADHD, depression, or anxiety than a neurodegenerative condition — but the clinician who never considers the rare diagnosis when the presentation warrants it is also making an error. Differential diagnosis requires balancing probability with possibility.
-
Overdiagnosing comorbidity when a single diagnosis explains the presentation. Parsimony matters. If a client's anxiety, irritability, insomnia, and concentration difficulty are all better accounted for by PTSD, listing GAD, insomnia disorder, and ADHD as additional diagnoses adds diagnostic noise without clinical value. The DSM-5-TR differential diagnosis tables help clinicians determine when symptoms are better accounted for by another condition.
Writing a assessment report right now?
My Clinical Writer helps you draft assessment reports from your session details in under 60 seconds.
Try My Clinical Writer Free →myclinicalwriter.ai
Frequently Asked Questions
Related Templates
External Resources
Authoritative references and tools related to this documentation type.
Stop spending hours on documentation
My Clinical Writer uses AI to help you draft clinical notes, treatment plans, and reports in minutes — not hours.
Get Started at myclinicalwriter.ai →